Aspirin intolerance and allergy to house dust mites: Important factors associated with development of severe asthma

Annals of Allergy, Asthma and Immunology

Volumn 92, Issue 4, 2004, Pages 453-458

  Kupczyk, Maciej ^a   Kupryś, Izabela ^a   Górski, Paweł ^a   Kuna, Piotr ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLERGEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGE; AGED; ANAMNESIS; ARTICLE; ASTHMA; ATOPY; COHORT ANALYSIS; DISEASE DURATION; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; FEMALE; FOLLOW UP; GENDER; HOUSE DUST ALLERGY; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; OUTPATIENT DEPARTMENT; PATHOGENESIS; POLAND; PRICK TEST; PRIORITY JOURNAL; RANDOMIZATION; RISK ASSESSMENT; RISK FACTOR; SPIROMETRY; ADOLESCENT; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; HOSPITALIZATION; IMMUNOLOGY; MIDDLE AGED; PYROGLYPHIDAE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SKIN TEST; STATISTICS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ALLERGENS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POLAND; PYROGLYPHIDAE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SKIN TESTS; STATISTICS;

EID: 3042725664     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61782-6     Document Type: Article

References (25)

1. Kupryg I, Elgalal A, Korzycka B, Gondorowicz K, Górski P, Kuna P. Epidemiology of bronchial asthma in the Lodz Province. Allergologie. 2000;23:419-420.
2. Clark TJ. Can management of asthma reduce costs? In: Godard P, Bousquet J, Michel FB, editors. Genetics of Allergy. Montpellier, France: Hogrefe Huber; 1996.
3. Dahlen B, Zetterstrom O. Comparison of bronchial and per oral provocation with aspirin in aspirin-sensitive asthmatics. Eur Respir J. 1990;3:527-534.
4. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. [National Heart, Lung, and Blood Institute/WHO workshop]. Available at: www.ginasthma.com.
5. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis. 1983;127:725-734.
6. Kupczyk M, Kupryś I, Górski P, Kuna P. Not one lancet for multiple SPT. Allergy. 2001;56:256-257.
7. Position paper: Allergen standardization and skin tests. The European Academy of Allergology and Clinical Immunology. Allergy. 1993;48(Suppl):48-82.
8. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med. 2000;342:1878-1886.
9. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342:1887-1892.
10. Haahtela T, Laitinen LA. Asthma programme in Finland 1994-2004. Report of a Working Group. Clin Exp Allergy. 1996;26(Suppl):i-ii, 1-24.
11. Makino S. East-west: role of asthma management guidelines. Presented at: International Conference on Asthma '99: Theory to Treatment; April 30-May 3, 1999; Honolulu, Hawaii: 31-40.
12. Parameswaran K, Hildreth AJ, Taylor IK, Keaney NP, Bansal SK. Predictors of asthma severity in the elderly: results of a community survey in Northeast England. J Asthma. 1999;36:613-618.
13. Bavbek S, Celik G, Ediger D, et al. Severity and associated risk factors in adult asthma patients in Turkey. Ann Allergy Asthma Immunol. 2000;85:134-139.
14. Silverstein MD, Reed CE, O'Connell EJ, Melton LJ III, O'Fallon WM, Yunginger JW. Long-term survival of a cohort of community residents with asthma. N Engl J Med. 1994;331:1537-1541.
15. Lange P, Ulrik CS, Vestbo J. Mortality in adults with self-reported asthma. Copenhagen City Heart Study Group. Lancet. 1996;347:1285-1289.
16. Huovinen E, Kaprio J, Vesterinen E, Koskenvuo M. Mortality of adults with asthma: a prospective cohort study. Thorax. 1997;52:49-54.
17. Zeiger RS, Dawson C, Weiss S. Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP). J Allergy Clin Immunol. 1999;103:376-387.
18. Rosenstreich DL. Relationship between sensitization, allergen levels and asthma morbidity in inner city children. In: Program and Abstracts of the Annual Meeting of the American Thoracic Society, 1996. Abstract A255.
19. Squillace SP, Sporik RB, Rakes G, et al. Sensitization to dust mites as a dominant risk factor for asthma among adolescents living in central Virginia. Multiple regression analysis of a population-based study. Am J Respir Crit Care Med. 1997;156:1760-1764.
20. Peat JK, Tovey E, Toelle BG, et al. House dust mite allergens: a major risk factor for childhood asthma in Australia. Am J Respir Crit Care Med. 1996;153:141-146.
21. Arlian LG, Platts-Mills TA. The biology of dust mites and the remediation of mite allergens in allergic disease. J Allergy Clin Immunol. 2001;107(Suppl):S406-S413.
22. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol. 1999;104:5-13.
23. Szczeklik A, Niżankowska E, Duplaga M. Natural history of aspirin-induced asthma. European Network on Aspirin-Induced Asthma. AIANE Investigators. Eur Respir J. 2000;16:432-436.
24. 4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest. 1998;101:834-846.
25. Lange P, Pamer J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med. 1998;339:1194-1200.